Advertisement

Author: Jakob Emerson

Advertisement

Some health insurers are cracking down on off-label prescriptions of new weight loss drugs such as Ozempic, The Washington Post reported June 12.

The Biden administration has reached a tentative deal that would preserve a provision of the ACA requiring insurers to cover preventive services while a Texas judge's ruling against the mandate is appealed in court.

Unlike other large payers, individual Blue Cross Blue Shield companies are not publicly traded, making it difficult to find public executive compensation figures.

Advertisement